MYOact GmbH

What MYOact GmbH does

MYOact GmbH is a Frankfurt am Main-based health-technology company founded in 2021 by physiotherapists Simon Roth and Philipp Piroth to commercialize surface electromyography (EMG) for everyday clinical and training practice. The company combines wireless Bluetooth EMG sensors (Cometa PicoBlue bundled; Noraxon Ultium compatible) with a tablet-based "myoact App" registered as an EU Class 1 medical device, delivered via three modes: standardized myoact Mapping (sub-3-minute muscle analysis with auto-generated reports and Balance Score), real-time EMG Biofeedback training, and a Training mode for performance target setting. The system is positioned as a portable, plug-and-play alternative to laboratory-grade EMG, designed for physicians, physiotherapists, sports-medicine specialists, and trainers who need objective functional imaging of muscle activity that structural imaging (MRI, CT, X-ray) cannot provide.

The business model is B2B direct sales on a subscription basis: monthly licenses range from €149 (software only) to €344 (license plus 4 sensors) and annual licenses from €1,499 to €3,638, with one-time hardware purchase options at €4,999 (2 sensors) and €7,499 (4 sensors). MYOact supports licensees in building billable self-pay EMG services to end patients and athletes, effectively creating a downstream revenue layer on the same installed base. Distribution is exclusively direct (live online demos, quote requests, Stripe-powered self-serve on the pricing page, [email protected]), with primary geographic markets in Germany and an early-stage beachhead in Denmark (myoact.dk). Reference customers include Eintracht Frankfurt (Bundesliga), NBA athletes (via affiliated physiotherapist), Kaiser Karl Klinik Bonn, University Clinic Ulm, and a broad long tail of small practices and individual trainers.

Strategically, MYOact is building moats around EU medical-device registration, founder domain expertise, standardized mapping protocols, an interdisciplinary user community and knowledge base, and a growing dataset of EMG measurements that feeds an AI-supported analysis layer. The company is in an early commercial stage with multiple ecosystem partnerships (ESA BIC Hessen, German Accelerator, TechQuartier, Frankfurt Forward), active event and content marketing, and no publicly disclosed revenue, funding amount, or headcount trend.

Name

MYOact GmbH

Legal name

MYOact GmbH

Website

https://myoact.de

Company type

Private

Founded year

2021

Operating status

Operating

Headcount range

11–50 employees

Short description

MYOact GmbH is a Frankfurt-based health-technology company that sells a subscription-based surface EMG analysis and biofeedback system — wireless Bluetooth sensors paired with an EU-registered Class 1 medical device app — to physicians, physiotherapists, sports-medicine specialists, and trainers, primarily in Germany with early expansion into Denmark.

Ownership category

akta.pro rank

Product category

EMG Biofeedback Systems

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Navigational, Measuring, Electromedical, and Control Instruments Manufacturing (33451)

SIC

Electromedical & Electrotherapeutic Apparatus (3845), Surgical & Medical Instruments & Apparatus (3841)

akta.pro primary industry

Connected Medical Devices & Wearables (Sensors, Patches, Implantables) (HLACAPAB)

akta.pro secondary industry

Smart Fitness & Training Devices (Connected Fitness Sensors, Smart Jump Ropes, etc.) (CRACAQAH)

Keywords

• EMG biofeedback systems
• Surface electromyography devices
• Muscle imbalance analysis
• Physiotherapy assessment tools
• Rehabilitation monitoring software

Headquarters

HQ city

Frankfurt

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Technology or R&D, Personnel, Supply Chain, Marketing or Sales, Operations

Revenue model

1. Software License (SaaS): Monthly or annual subscription for access to the myoact EMG analysis and biofeedback app. Includes all software updates, feature upgrades, access to the digital knowledge base, and personal support. Tiered by sensor count (2 or 4 sensors) and billing cadence (monthly or annual). Monthly licenses are cancelable at any time; annual licenses have a 12-month minimum term.
2. EMG Sensor Hardware (Sale or Lease): Cometa EMG sensors sold outright or bundled as part of the monthly/all-in license. 2-sensor purchase option at €4,999 net; 4-sensor option at €7,000 net (pricing page) or €7,499 net (license page). Lease options also available. Sensors are also provided as part of the monthly rental license with replacement coverage for defects included.
3. Professional Education & Training: Online courses, live workshops, webinars, and certification programs provided as part of the license package (free for licensees). Content covers EMG fundamentals, application, data interpretation, and integration into therapy workflows. Customer Success team supports pricing structure development for self-pay services.
4. Self-Payer / Private Pay Services (Customer Upsell): Licensees use the myoact system to deliver billable EMG analysis and biofeedback services as self-pay offerings to patients and athletes, private health insurance clients, or as add-on services. The company supports partners in building these business models through webinars and Customer Success support.

Pricing tiers

Go-to-market motion3 records

Distribution channels3 records

Marketing channels8 records

Core offering

MYOact GmbH sells a surface EMG (electromyography) biofeedback system consisting of wireless Bluetooth sensors paired with a tablet-based analysis and training app registered as an EU Class 1 medical device. The system enables physicians, physiotherapists, and sports trainers to visualize muscular imbalances, perform standardized muscle mapping tests in under 3 minutes, deliver real-time biofeedback training, and automatically generate patient reports. The offering is sold exclusively as a monthly or annual subscription license, with optional bundled wireless EMG sensors (Cometa PicoBlue or compatible Noraxon Ultium).

Product overview

MYOact GmbH offers a unified EMG (electromyography) biofeedback platform consisting of the myoact App (an EU-registered Class 1 medical device) paired with wireless Bluetooth EMG sensors (Cometa PicoBlue or Noraxon Ultium). The offering is delivered exclusively as a subscription/license model (monthly from 149 €/month for software only, or 279–344 €/month for all-in bundles including sensors). The core app supports three operational modes: myoact Mapping for standardized muscle analysis, EMG Biofeedback Training for real-time patient feedback, and a Training mode for performance target setting. The platform targets physicians, physiotherapists, rehabilitation specialists, and trainers, and is used by professional sports organizations including Eintracht Frankfurt and NBA athletes.

Differentiator

Problem solved

Functional benefit

Products and services

• myoact EMG Analysis and Biofeedback App
• Cometa PicoBlue Wireless EMG Sensors
• myoact Knowledge Base and E-Learning Platform

Quantifiable outcome

• Analysis, direct interpretation, and therapy recommendation completed in under 2–3 minutes per patient session
• +3 more outcomes

Named customers8 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

AI capability3 records

Feature7 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• ESA Business Incubation Centre HessencoreStrategic or Co-development PartnerMYOact GmbH is a participating company in the ESA Business Incubation Centre Hessen, a European Space Agency incubation program supporting innovative technology startups. MYOact's technology involves advanced sensor technology relevant to space and astronaut health monitoring applications. The partnership provides access to ESA's innovation ecosystem, technical expertise, and credibility boost as a supported innovator. The company displays the ESA BIC Hessen logo on its impressum and website.
• German AcceleratorcoreStrategic or Co-development PartnerMYOact participates in the German Accelerator program, which supports high-potential German startups in scaling internationally. The partnership provides access to mentorship, networks, and resources for international market expansion.
• TechQuartier (Hessen 10 Program)minorStrategic or Co-development PartnerMYOact participates in the TechQuartier's Hessen 10 program, a startup support initiative in the Frankfurt/Rhein-Main region. TechQuartier is a central innovation hub connecting startups with corporate partners and investors.
• Frankfurt ForwardminorStrategic or Co-development PartnerMYOact has been recognized as a Frankfurt Forward startup and was named Startup of the Year by the initiative, which promotes Frankfurt's startup ecosystem internationally.
• Eintracht FrankfurtcoreStrategic or Co-development PartnerEintracht Frankfurt has implemented EMG screenings using the myoact system as part of their athlete health and performance management program. This partnership represents a reference customer relationship with a Bundesliga professional football club, validating the technology in elite sports.
• NSCA (National Strength and Conditioning Association Germany)minorGTM or Marketing PartnerListed as a science and media partner. NSCA Germany is a professional association for strength and conditioning coaches and sports scientists. The partnership provides access to a professional community of trainers and coaches as potential customers.
• University Clinic Ulm – Sports and Rehabilitation MedicinecoreStrategic or Co-development PartnerDr. med. Alexander-Stephan Henze from the University Clinic Ulm collaborates with myoact on webinars, case studies, and clinical research in sports medicine. The partnership lends scientific credibility and provides clinical expertise for product development and educational content.
• BodyLife (Trade Media)minorGTM or Marketing PartnerBodyLife publishes training and physiotherapy content and featured myoact in a title special (bodyLIFE Ausgabe 1/2024). The partnership provides editorial media coverage reaching fitness industry professionals and decision-makers.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• Vald Performance: Vald Performance makes clinical and sports-performance assessment systems (force plates, NordBord, dynamometry) used in physiotherapy, elite sports, and research. It overlaps with MYOact in objective MSK and performance assessment targeting physiotherapists and sports scientists, though via different modalities.
• Catapult Sports: Catapult is a category leader in athlete tracking and performance monitoring (GPS, inertial sensors) used by Eintracht Frankfurt and other professional clubs. It is adjacent rather than direct — Catapult covers load and movement rather than muscle activation — but it competes for the same elite-sports performance budgets and stitch-in relationships.

Direct peers

• Noraxon USA: Noraxon manufactures surface EMG and motion-capture systems (including the Ultium sensors referenced as compatible with MYOact's software). It is the closest direct competitor in clinical and sports EMG and a partial supplier to MYOact at the same time.
• Thought Technology Ltd. Thought Technology is a leading provider of physiological monitoring and biofeedback systems (EMG, EEG, EDA) used by clinicians, physiotherapists, and researchers. It competes in EMG biofeedback and rehabilitation use cases central to MYOact's product.
• Cometa (Wave Medical): Cometa makes wireless EMG sensors (PicoBlue) that are integrated and bundled with the myoact license packages. It is both a key hardware partner and a potential competitor offering its own EMG platforms in clinical and research markets.
• Delsys: Delsys is a long-established manufacturer of Trigno wireless surface EMG sensors and software used in clinical biomechanics, rehabilitation, and sports. It competes in the same core modality (surface EMG biofeedback and analysis) for similar medical, research, and performance customers.
• Mind Media Netherlands: Mind Media produces biofeedback and neurofeedback hardware/software (NeXus) used for EMG, ECG, EEG, and respiration monitoring in clinical and research settings. It targets similar physiotherapist and rehabilitation specialist buyers with biofeedback-driven therapy tools.
• BTS Bioengineering: BTS Bioengineering makes clinical and research-grade movement analysis and EMG systems (e.g., FREEEMG, Smart-DX) used in rehabilitation and sports medicine. It overlaps with MYOact in EMG-based assessment for gait, posture, and rehabilitation, with comparable professional and clinical buyers.

Emerging players

• KinaTrax: KinaTrax provides markerless motion-capture technology for elite sports performance, injury prevention, and rehabilitation. It competes for the same professional sports budgets (e.g., MLB, NBA) and addresses some of the same functional assessment needs as MYOact's EMG-based imbalance analysis.
• mBrainTrain: mBrainTrain offers wearable EEG/EMG-capable mobile brain monitoring devices used in research and applied human-performance settings. It overlaps with MYOact in surface EMG for performance and rehabilitation, primarily serving research and performance rather than routine clinical use.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@myoact-emg
• Facebookfacebook.com/myoactemg
• LinkedInlinkedin.com/company/myoact-gmbh
• Instagraminstagram.com/myoact/?hl=de
• TikToktiktok.com/@myoact

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about MYOact GmbH